MedPath

Visual Reconstitution Therapy After Optic Neuritis

Phase 2
Completed
Conditions
Optic Neuritis
Multiple Sclerosis
Interventions
Other: Visual Reconstitutions Therapy
Other: Saccadic Eye Movement Training
Registration Number
NCT01274702
Lead Sponsor
Friedemann Paul
Brief Summary

Incomplete remission after an optic neuritis attack is not uncommon. Visual reconstitution therapy is a software-based approach that has been shown to substantially improve residual visual field deficits in patients with pre- and postchiasmatic lesions.

The primary hypothesis of this randomized, controlled clinical trial is, that visual reconstitution therapy is superior to active comparator treatment in improving the visual field after optic neuritis.

Detailed Description

Patients with an acute optic neuritis (between 60 and 180 days before screening) or with residual visual deficits after a past optic neuritis are randomized in two treatment groups. Group A is instructed to perform software-based visual reconstitution therapy on a home PC daily and regularly for 30 minutes over a period of six month. Group B will perform a similarly, also software-based training program, developed to improve saccadic eye movements rather than visual fields. Patients are blinded to the respective treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Definite Optic Neuritis within 60-180 Days or < 12 months before Screening
  • Visus > 0.05
  • Visus < 0.7 or confirmed visual field deficit
  • Ability to give Informed Consent
Exclusion Criteria
  • Systemic Treatment with Glucocorticosteroids within 30 days prior to Screening
  • Additional significant ophthalmological disease
  • Pregnancy
  • History of Epilepsy
  • Significant arterial Hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Visual Reconstitution TherapyVisual Reconstitutions Therapy-
Saccadic Eye Movement TrainingSaccadic Eye Movement Training-
Primary Outcome Measures
NameTimeMethod
Visual field6 months

visual field perimetry and kampimetry at baseline and after 3 and 6 months

Secondary Outcome Measures
NameTimeMethod
Quality of Life6 months

Quality of life is determined by questionaires at baseline and after 6 months

structural retinal changes6 months

Optical coherence Tomography is performe at baselline and after 6 months

Trial Locations

Locations (1)

NeuroCure Clinical Reserach Center, Charité Universitaetsmedizin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath